Bioventus, Inc. (BVS)
9.95
-0.67
(-6.31%)
USD |
NASDAQ |
Nov 19, 16:00
9.96
+0.01
(+0.10%)
After-Hours: 20:00
Bioventus Total Liabilities (Quarterly) : 381.56M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 381.56M |
| June 30, 2026 | 395.93M |
| March 31, 2026 | 416.27M |
| December 31, 2025 | 455.11M |
| September 30, 2025 | 494.34M |
| June 30, 2025 | 505.49M |
| March 31, 2025 | 505.94M |
| December 31, 2024 | 542.35M |
| September 30, 2024 | 582.66M |
| June 30, 2024 | 603.11M |
| March 31, 2024 | 576.81M |
| December 31, 2023 | 589.79M |
| September 30, 2023 | 584.65M |
| June 30, 2023 | 603.62M |
| March 31, 2023 | 647.04M |
| December 31, 2022 | 960.43M |
| September 30, 2022 | 1.019B |
| June 30, 2022 | 688.59M |
| March 31, 2022 | 675.22M |
| December 31, 2021 | 692.07M |
| September 30, 2021 | 424.29M |
| June 30, 2021 | 427.27M |
| Date | Value |
|---|---|
| March 31, 2021 | 422.79M |
| December 31, 2020 | 350.31M |
| September 30, 2020 | 333.94M |
| June 30, 2020 | 367.62M |
| March 31, 2020 | |
| December 31, 2019 | 326.79M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 299.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Accuray, Inc. | 336.94M |
| Orthofix Medical, Inc. | 426.19M |
| ResMed, Inc. | 2.264B |
| Rockwell Medical, Inc. | 23.95M |
| Microbot Medical, Inc. | 4.764M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 673.43M |
| Shareholders Equity (Quarterly) | 240.50M |
| Debt to Equity Ratio | 1.015 |
| Current Ratio | 1.684 |
| Net Debt Paydown Yield | 2.50% |